Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Critical Reviews in Toxicology
|
July 6, 2011
Animal models of idiosyncratic drug-induced liver injury--current status
Robert A Roth, Patricia E Ganey
The Journal of Pharmacology and Experimental Therapeutics
|
December 19, 2009
Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?
Robert A Roth, Patricia E Ganey
Expert Opinion on Drug Metabolism & Toxicology
|
April 24, 2020
What have we learned from animal models of idiosyncratic, drug-induced liver injury?
Robert A Roth, Patricia E Ganey
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 21, 2004
Workshop overview: Hepatotoxicity assessment for botanical dietary supplements
Kristine L Willett, Robert A Roth, Larry Walker
Pharmacology & Therapeutics
|
October 19, 2006
Hypoxia, drug therapy and toxicity
KangAe Lee, Robert A Roth, John J LaPres
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2012
Complement activation in acetaminophen-induced liver injury in mice
Rohit Singhal, Patricia E Ganey, Robert A Roth
Toxicology
|
August 21, 2003
Liver inflammation during monocrotaline hepatotoxicity
Bryan L Copple, Patricia E Ganey, Robert A Roth
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 7, 2012
Hypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α
Erica M Sparkenbaugh, Patricia E Ganey, Robert A Roth
The Journal of Pharmacology and Experimental Therapeutics
|
September 30, 2008
Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure
Patrick J Shaw, Patricia E Ganey, Robert A Roth
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 12, 2010
Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity
Patrick J Shaw, Patricia E Ganey, Robert A Roth
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Critical Reviews in Toxicology
|
July 6, 2011
Animal models of idiosyncratic drug-induced liver injury--current status
Robert A Roth, Patricia E Ganey
The Journal of Pharmacology and Experimental Therapeutics
|
December 19, 2009
Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?
Robert A Roth, Patricia E Ganey
Expert Opinion on Drug Metabolism & Toxicology
|
April 24, 2020
What have we learned from animal models of idiosyncratic, drug-induced liver injury?
Robert A Roth, Patricia E Ganey
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 21, 2004
Workshop overview: Hepatotoxicity assessment for botanical dietary supplements
Kristine L Willett, Robert A Roth, Larry Walker
Pharmacology & Therapeutics
|
October 19, 2006
Hypoxia, drug therapy and toxicity
KangAe Lee, Robert A Roth, John J LaPres
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2012
Complement activation in acetaminophen-induced liver injury in mice
Rohit Singhal, Patricia E Ganey, Robert A Roth
Toxicology
|
August 21, 2003
Liver inflammation during monocrotaline hepatotoxicity
Bryan L Copple, Patricia E Ganey, Robert A Roth
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 7, 2012
Hypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α
Erica M Sparkenbaugh, Patricia E Ganey, Robert A Roth
The Journal of Pharmacology and Experimental Therapeutics
|
September 30, 2008
Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure
Patrick J Shaw, Patricia E Ganey, Robert A Roth
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 12, 2010
Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity
Patrick J Shaw, Patricia E Ganey, Robert A Roth
Page
of 9